Skip to main content
HR 4083 110th Congress House

Non-Prescription Drug Modernization Act of 2007

Official title: To amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority … Show full official titleShow less

Official title: To amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes.

Introduced: December 19, 2007 See on congress.gov
Health Administrative procedureCommerceCongressCongressional reporting requirements
More subjectsShow fewer subjects
Consumer educationDeceptive advertisingDepartment of Health and Human ServicesDrug adulterationDrug industryDrugsFood and Drug Administration (FDA)Government Operations and PoliticsLabelingLaw
Sign in to write a letter Sign in to watch
This bill died when the 110th Congress ended
It never became law before the 110th Congress (2007–2008) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 6, 2007
Referred to the House Committee on Energy and Commerce.
Nov 6, 2007
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 6, 2007

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Non-Prescription Drug Modernization Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to authorize: (1) the amendment or repeal of an over-the-counter drug monograph without notice and public procedure if there is a finding by the Secretary of Health and Human Services that a category of drugs or a specific drug is associated with a significant risk or that such drugs lack evidence of effectiveness; and (2) the Food and Drug Administration (FDA) to regulate over-the-counter drug advertisements.

Directs the Commissioner of Food and Drugs to identify over-the-counter drug monographs that may require amendment or repeal and to report the findings to Congress.

 Related & companion bills 1
  • S 2311 Identical bill Non-Prescription Drug Modernization Act of 2007
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2
D
Cohen, Steve
Tennessee · Dec 19, 2007
 D
DeGette, Diana
Colorado · Dec 11, 2007
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4083: Non-Prescription Drug Modernization Act of 2007. 110th Congress. Open America. https://openamerica.io/bill/110-HR-4083/
MLA
"H.R. 4083: Non-Prescription Drug Modernization Act of 2007." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HR-4083/.
Bluebook (legal)
H.R. 4083, 110th Cong. (2026), https://openamerica.io/bill/110-HR-4083/.
Markdown link
[H.R. 4083: Non-Prescription Drug Modernization Act of 2007](https://openamerica.io/bill/110-HR-4083/)
Report a problem